Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Cervical Cancer, October 2021

Free Subscription


Abstracts

Retrieve all available abstracts of the following 273 articles:
HTML format


 

Single Articles

  1. XIAO C, Tong C, Fan J, Wang Z, et al
    Biomimetic nanoparticles loading with gamabutolin-indomethacin for chemo/photothermal therapy of cervical cancer and anti-inflammation.
    J Control Release. 2021 Sep 28. pii: S0168-3659(21)00513.
    PubMed    
    Abstract available

  2. HUANG J, Chen J, Huang Q
    The profile analysis of circular RNAs in cervical cancer.
    Medicine (Baltimore). 2021;100:e27404.
    PubMed    
    Abstract available

  3. LIU F, Wu X, Zhu H, Wang F, et al
    Dysregulated expression of circular RNAs serve as diagnostic and prognostic markers in ovarian and cervical cancer: A PRISMA-compliant systematic review and meta-analysis.
    Medicine (Baltimore). 2021;100:e27352.
    PubMed    
    Abstract available

  4. MANRRIQUEZ EN, Zakhour M, Salani R
    Precision medicine for cervical cancer.
    Curr Opin Obstet Gynecol. 2021 Oct 1. pii: 00001703-900000000-99091.
    PubMed    
    Abstract available

  5. NOSAKA K, Suzuki S, Yoshikawa T, Shimomura M, et al
    Heat Shock Protein 105 as an Immunotherapeutic Target for Patients With Cervical Cancer.
    Anticancer Res. 2021;41:4741-4751.
    PubMed    
    Abstract available

  6. CLEARY JF
    Cervical Cancer: 90-70-90 and Palliative Care.
    JCO Glob Oncol. 2021;7:1426-1428.
    PubMed    


  7. LI X, Xu Z, Shen X, Zhou Y, et al
    Detection of Cervical Cancer Cells in Whole Slide Images Using Deformable and Global Context Aware Faster RCNN-FPN.
    Curr Oncol. 2021;28:3585-3601.
    PubMed    
    Abstract available

  8. AL-SARAIREH YM, Alshammari FOFO, Youssef AMM, Al-Sarayra YM, et al
    Cytochrome 4Z1 Expression Is Correlated with Poor Prognosis in Patients with Cervical Cancer.
    Curr Oncol. 2021;28:3573-3584.
    PubMed    
    Abstract available

  9. JI F, Lu Y, Chen S, Lin X, et al
    m(6)A methyltransferase METTL3-mediated lncRNA FOXD2-AS1 promotes the tumorigenesis of cervical cancer.
    Mol Ther Oncolytics. 2021;22:574-581.
    PubMed    
    Abstract available

  10. ZHU X, Ren J, Xu D, Cheng D, et al
    Upregulation of Translationally Controlled Tumor Protein Is Associated With Cervical Cancer Progression.
    Front Mol Biosci. 2021;8:686718.
    PubMed    
    Abstract available

  11. YAN J, Zheng Z, Zhu J, Hu K, et al
    Radiotherapy for Vaginal Recurrences of Cervical Cancer in Patients After Prior Surgery: Analysis of Effect and Prognostic Factors.
    Front Oncol. 2021;11:744871.
    PubMed    
    Abstract available

  12. LI W, Zhang W, Sun L, Wang L, et al
    Neoadjuvant Chemotherapy Followed by Surgery Versus Abdominal Radical Hysterectomy Alone for Oncological Outcomes of Stage IB3 Cervical Cancer-A Propensity Score Matching Analysis.
    Front Oncol. 2021;11:730753.
    PubMed    
    Abstract available

  13. AZUMI M, Matsumoto M, Suzuki K, Sasaki R, et al
    PET/MRI is useful for early detection of pelvic insufficiency fractures after radiotherapy for cervical cancer.
    Oncol Lett. 2021;22:776.
    PubMed    
    Abstract available

  14. AN M, Xing X, Chen T
    Long non-coding RNA UCA1 enhances cervical cancer cell proliferation and invasion by regulating microRNA-299-3p expression.
    Oncol Lett. 2021;22:772.
    PubMed    
    Abstract available

  15. ZHANG C, Liu P, Huang J, Liao Y, et al
    Circular RNA hsa_circ_0043280 inhibits cervical cancer tumor growth and metastasis via miR-203a-3p/PAQR3 axis.
    Cell Death Dis. 2021;12:888.
    PubMed    
    Abstract available

  16. LIN Y, Dong P, Shi D, Mao Z, et al
    Clinical values of transrectal ultrasound in judging GTV of cervical cancer.
    Brachytherapy. 2021 Sep 26. pii: S1538-4721(21)00457.
    PubMed    
    Abstract available

  17. BAIOCCHI G, Ribeiro R, Dos Reis R, Lopes A, et al
    ASO Author Reflections: Minimally Invasive Radical Hysterectomy in Cervical Cancer: A Brazilian Multicentric Cohort Study (CIRCOL).
    Ann Surg Oncol. 2021 Sep 29. pii: 10.1245/s10434-021-10875.
    PubMed    


  18. ROBBERS GML, Bennett LR, Spagnoletti BRM, Wilopo SA, et al
    Facilitators and barriers for the delivery and uptake of cervical cancer screening in Indonesia: a scoping review.
    Glob Health Action. 2021;14:1979280.
    PubMed    
    Abstract available

  19. HUANG D, Li C
    circ-ACACA promotes proliferation, invasion, migration and glycolysis of cervical cancer cells by targeting the miR-582-5p/ERO1A signaling axis.
    Oncol Lett. 2021;22:795.
    PubMed    
    Abstract available


  20. miRNA-641 Inhibits the Proliferation, Migration, and Invasion and Induces Apoptosis of Cervical Cancer Cells by Directly Targeting ZEB1 [Retraction].
    Onco Targets Ther. 2021;14:4849-4850.
    PubMed    
    Abstract available

  21. YIN X, Lu Y, Zou M, Wang L, et al
    Synthesis and Characterization of Salinomycin-Loaded High-Density Lipoprotein and Its Effects on Cervical Cancer Cells and Cervical Cancer Stem Cells.
    Int J Nanomedicine. 2021;16:6367-6382.
    PubMed    
    Abstract available

  22. KUNO I, Takayanagi D, Asami Y, Murakami N, et al
    TP53 mutants and non-HPV16/18 genotypes are poor prognostic factors for concurrent chemoradiotherapy in locally advanced cervical cancer.
    Sci Rep. 2021;11:19261.
    PubMed    
    Abstract available

  23. HU X, Sun M, Tang S, Lommel LL, et al
    Frequency of basic public health services utilization by married female migrants in China: associations of social support, discrimination and sociodemographic factors.
    BMC Womens Health. 2021;21:344.
    PubMed    
    Abstract available

  24. BOTKIN HE, Faidley KN, Loeffler BT, Mott SL, et al
    Longitudinal Outcomes from Conservative Management of Cervical Cancer Associated Ureteral Obstruction.
    Urology. 2021 Sep 25. pii: S0090-4295(21)00895.
    PubMed    
    Abstract available

  25. TSHEWANG U, Satiracoo P, Lenbury Y
    Survival Analysis of Cervical Cancer Patients: A Case Study of Bhutan.
    Asian Pac J Cancer Prev. 2021;22:2987-2993.
    PubMed    
    Abstract available

  26. TOVANABUTRA C, Asakij T, Rongsriyam K, Tangjitgamol S, et al
    Long-Term Outcomes and Sites of Failure in Locally Advanced, Cervical Cancer Patients Treated by Concurrent Chemoradiation with or without Adjuvant Chemotherapy: ACTLACC Trial.
    Asian Pac J Cancer Prev. 2021;22:2977-2985.
    PubMed    
    Abstract available

  27. HASHEMZEHI A, Karimi-Zarchi M, Parsaeian SF, Asadian F, et al
    Association of IL-6 -174G>C and -572G>C Polymorphisms with Susceptibility to Cervical Cancer and Ovarian Cancer.
    Asian Pac J Cancer Prev. 2021;22:2867-2871.
    PubMed    
    Abstract available

  28. BARNABAS RV, Brown ER, Onono M, Bukusi EA, et al
    Single-dose HPV vaccination efficacy among adolescent girls and young women in Kenya (the KEN SHE Study): study protocol for a randomized controlled trial.
    Trials. 2021;22:661.
    PubMed    
    Abstract available

  29. WANG X, Li J, Hua K, Chen Y, et al
    Vaginal-assisted gasless laparoendoscopic single-site radical hysterectomy for early cervical cancer: a retrospective pilot study.
    World J Surg Oncol. 2021;19:288.
    PubMed    
    Abstract available

  30. SADOUGHI F, Hallajzadeh J, Asemi Z, Mansournia MA, et al
    Nanocellulose-based delivery systems and cervical cancer: Review of the literature.
    Curr Pharm Des. 2021 Sep 27. pii: CPD-EPUB-118187.
    PubMed    
    Abstract available

  31. PANDEY P, Khan F, Alzahrani FA, Qari HA, et al
    A Novel Approach to Unraveling the Apoptotic Potential of Rutin (Bioflavonoid) via Targeting Jab1 in Cervical Cancer Cells.
    Molecules. 2021;26.
    PubMed    
    Abstract available

  32. MARIMA R, Hull R, Lolas G, Syrigos KN, et al
    The Catastrophic HPV/HIV Dual Viral Oncogenomics in Concert with Dysregulated Alternative Splicing in Cervical Cancer.
    Int J Mol Sci. 2021;22.
    PubMed    
    Abstract available

  33. SIM JH, Lee JS, Jang DM, Kim HJ, et al
    Effects of Perioperative Inflammatory Response in Cervical Cancer: Laparoscopic versus Open Surgery.
    J Clin Med. 2021;10.
    PubMed    
    Abstract available

  34. KANAO H, Aoki Y, Fusegi A, Omi M, et al
    Feasibility and Outcomes of "No-Look No-Touch" Laparoscopic Radical Trachelectomy for Early-Stage Cervical Cancer.
    J Clin Med. 2021;10.
    PubMed    
    Abstract available

  35. OIKE T, Oike T, Ando K, Iwase A, et al
    The Non-Cancer Specific Elevation of the Serum Squamous Cell Carcinoma Antigen during the Post-Radiotherapy Follow-Up of Cervical Cancer Patients.
    Diagnostics (Basel). 2021;11.
    PubMed    
    Abstract available

  36. HAYASHI S, Iwata T, Imagawa R, Sugawara M, et al
    Transcription Factor Homeobox D9 Drives the Malignant Phenotype of HPV18-Positive Cervical Cancer Cells via Binding to the Viral Early Promoter.
    Cancers (Basel). 2021;13.
    PubMed    
    Abstract available

  37. CHEN YH, Wu JX, Yang SF, Chen ML, et al
    Metformin Potentiates the Anticancer Effect of Everolimus on Cervical Cancer In Vitro and In Vivo.
    Cancers (Basel). 2021;13.
    PubMed    
    Abstract available

  38. KIM H, Kim MW, Jeong YI, Yang HS, et al
    Redox-Sensitive and Folate-Receptor-Mediated Targeting of Cervical Cancer Cells for Photodynamic Therapy Using Nanophotosensitizers Composed of Chlorin e6-Conjugated beta-Cyclodextrin via Diselenide Linkage.
    Cells. 2021;10.
    PubMed    
    Abstract available

  39. ZHANG W, Wu Q, Liu Y, Wang X, et al
    LncRNA HOTAIR promotes chemoresistance by facilitating epithelial to mesenchymal transition through miR-29b/PTEN/PI3K signaling in cervical cancer.
    Cells Tissues Organs. 2021 Sep 27. pii: 000519844. doi: 10.1159/000519844.
    PubMed    


  40. SHI S, Ma HY, Zhang ZG
    Clinicopathological and prognostic value of STAT3/p-STAT3 in cervical cancer: A meta and bioinformatics analysis.
    Pathol Res Pract. 2021;227:153624.
    PubMed    
    Abstract available

  41. WANG Y, Li X, Wang S, Song Z, et al
    miR-3929 Inhibits Proliferation and Promotes Apoptosis by Downregulating Cripto-1 Expression in Cervical Cancer Cells.
    Cytogenet Genome Res. 2021 Sep 20:1-12. doi: 10.1159/000518521.
    PubMed    
    Abstract available

  42. WU A, Tang D, Wu A, Liu Y, et al
    Comparison of the Dosimetric Influence of Applicator Displacement on 2D and 3D Brachytherapy for Cervical Cancer Treatment.
    Technol Cancer Res Treat. 2021;20:15330338211041201.
    PubMed    
    Abstract available

  43. ST JOHN J, Reininger B, Balcazar H, Valerio-Shewmaker MA, et al
    What About Promotores? Promotores' Psychosocial Determinants That Influenced the Delivery of a Cervical Cancer Education Intervention to Hispanics.
    Front Public Health. 2021;9:689616.
    PubMed    
    Abstract available

  44. ZHU X, Long L, Xiao H, He X, et al
    Cancer-Derived Exosomal miR-651 as a Diagnostic Marker Restrains Cisplatin Resistance and Directly Targets ATG3 for Cervical Cancer.
    Dis Markers. 2021;2021:1544784.
    PubMed    
    Abstract available

  45. OFFOR JO, Okunade KS, Iwalokun BA, Oluwole AA, et al
    Evaluation of oxidative markers in women with invasive cervical cancer in Lagos, Nigeria.
    Ecancermedicalscience. 2021;15:1266.
    PubMed    
    Abstract available

  46. LOZAR T, Nagvekar R, Rohrer C, Dube Mandishora RS, et al
    Cervical Cancer Screening Postpandemic: Self-Sampling Opportunities to Accelerate the Elimination of Cervical Cancer.
    Int J Womens Health. 2021;13:841-859.
    PubMed    
    Abstract available

  47. YE X, Ye P, Zheng Y, Xia W, et al
    Efficacy of helical tomotherapy combined with CT-guided three-dimensional intracavitary brachytherapy in treatment of locally advanced cervical cancer.
    J BUON. 2021;26:1298-1305.
    PubMed    
    Abstract available

  48. WANG T, Li W, Ye B, Zhang S, et al
    FTO-stabilized lncRNA HOXC13-AS epigenetically upregulated FZD6 and activated Wnt/beta-catenin signaling to drive cervical cancer proliferation, invasion, and EMT.
    J BUON. 2021;26:1279-1291.
    PubMed    
    Abstract available

  49. MAYER AMS, Hall ML, Lach J, Clifford J, et al
    RSK1 vs. RSK2 Inhibitory Activity of the Marine beta-Carboline Alkaloid Manzamine A: A Biochemical, Cervical Cancer Protein Expression, and Computational Study.
    Mar Drugs. 2021;19.
    PubMed    
    Abstract available

  50. YUAN DD, Jia CD, Yan MY, Wang J, et al
    Circular RNA hsa_circ_0000730 restrains cell proliferation, migration, and invasion in cervical cancer through miR-942-5p/PTEN axis.
    Kaohsiung J Med Sci. 2021 Sep 25. doi: 10.1002/kjm2.12443.
    PubMed    
    Abstract available

  51. PEACE SM, Jennings AJ
    Prevalence of high-grade dysplasia in cytology-negative, HPV-positive cervical cancer screening.
    Arch Gynecol Obstet. 2021 Sep 25. pii: 10.1007/s00404-021-06208.
    PubMed    
    Abstract available

  52. CHENG S, Liu S, Yu J, Rao G, et al
    Robust whole slide image analysis for cervical cancer screening using deep learning.
    Nat Commun. 2021;12:5639.
    PubMed    
    Abstract available


  53. Pembrolizumab May Substantially Up Cervical Cancer Survival.
    Cancer Discov. 2021 Sep 24. pii: 2159-8290.CD-NB2021-0383.
    PubMed    
    Abstract available

  54. DE PREZ V, Jolidon V, Willems B, Cullati S, et al
    Cervical cancer screening programs and their context-dependent effect on inequalities in screening uptake: a dynamic interplay between public health policy and welfare state redistribution.
    Int J Equity Health. 2021;20:211.
    PubMed    
    Abstract available

  55. ONG J, Lee K, Choo SN, Loh S, et al
    Pseudoaneurysm of the uterine artery post loop electrosurgical excision procedure.
    BMC Womens Health. 2021;21:298.
    PubMed    
    Abstract available

  56. MARASHI T, Irandoost SF, Yoosefi Lebni J, Soofizad G, et al
    Exploring the barriers to Pap smear test in Iranian women: a qualitative study.
    BMC Womens Health. 2021;21:287.
    PubMed    
    Abstract available

  57. TAGNE SIMO R, Kiafon FB, Nangue C, Goura AP, et al
    Influence of HIV infection on the distribution of high-risk HPV types among women with cervical precancerous lesions in Yaounde, Cameroon.
    Int J Infect Dis. 2021;110:426-432.
    PubMed    
    Abstract available

  58. MCHOME B, Linde DS, Manongi R, Waldstroem M, et al
    Incident detection of human papillomavirus - a prospective follow-up study among Tanzanian women with a focus on HIV status.
    Int J Infect Dis. 2021;110:165-170.
    PubMed    
    Abstract available

  59. KIM SY, Hwang KA, Ann JH, Kim JH, et al
    Next-generation sequencing for typing human papillomaviruses and predicting multi-infections and their clinical symptoms.
    Microbiol Immunol. 2021;65:273-278.
    PubMed    
    Abstract available

  60. ARMITAGE R
    Cervical screening coverage in England before and during COVID-19.
    Public Health. 2021;198:e11.
    PubMed    


  61. AJAYI-SMITH A, van der Watt P, Mkwanazi N, Carden S, et al
    Novel small molecule inhibitor of Kpnbeta1 induces cell cycle arrest and apoptosis in cancer cells.
    Exp Cell Res. 2021;404:112637.
    PubMed    
    Abstract available

  62. ZHANG J, Wang R, Cheng L, Xu H, et al
    Celastrol inhibit the proliferation, invasion and migration of human cervical HeLa cancer cells through down-regulation of MMP-2 and MMP-9.
    J Cell Mol Med. 2021;25:5335-5338.
    PubMed    
    Abstract available

  63. SAFAEIAN M, Wright TC Jr, Stoler MH, Ranger-Moore J, et al
    The IMproving Primary Screening And Colposcopy Triage trial: human papillomavirus, cervical cytology, and histopathologic results from the baseline and 1-year follow-up phase.
    Am J Obstet Gynecol. 2021;225:278.
    PubMed    
    Abstract available

  64. EL-MESERY M, Seher A, El-Shafey M, El-Dosoky M, et al
    Repurposing of quinoline alkaloids identifies their ability to enhance doxorubicin-induced sub-G0/G1 phase cell cycle arrest and apoptosis in cervical and hepatocellular carcinoma cells.
    Biotechnol Appl Biochem. 2021;68:832-840.
    PubMed    
    Abstract available

  65. ROSSI PG, Carozzi F, Ronco G, Allia E, et al
    p16/ki67 and E6/E7 mRNA accuracy and prognostic value in triaging HPV DNA-positive women.
    J Natl Cancer Inst. 2020 Aug 3. pii: 5879994. doi: 10.1093.
    PubMed    
    Abstract available

  66. CUDJOE J, Budhathoki C, Roter D, Gallo JJ, et al
    Exploring Health Literacy and the Correlates of Pap Testing Among African Immigrant Women: Findings from the AfroPap Study.
    J Cancer Educ. 2021;36:441-451.
    PubMed    
    Abstract available

  67. KETEN HS, Ucer H, Dalgaci AF, Isik O, et al
    Knowledge, Attitude, and Behavior of Teachers Regarding HPV (Human Papillomavirus) and Vaccination.
    J Cancer Educ. 2021;36:584-590.
    PubMed    
    Abstract available

  68. AUDIGER C, Bovagnet T, Deghaye M, Kaufmanis A, et al
    Factors associated with participation in the organized cervical cancer screening program in the greater Paris area (France): An analysis among more than 200,000 women.
    Prev Med. 2021 Oct 5:106831. doi: 10.1016/j.ypmed.2021.106831.
    PubMed    
    Abstract available

  69. ESFAHANI SA, Torrado-Carvajal A, Amorim BJ, Groshar D, et al
    PET/MRI and PET/CT Radiomics in Primary Cervical Cancer: A Pilot Study on the Correlation of Pelvic PET, MRI, and CT Derived Image Features.
    Mol Imaging Biol. 2021 Oct 7. pii: 10.1007/s11307-021-01658.
    PubMed    
    Abstract available

  70. HOU X, Zhang H, Nie Y, Zhang Y, et al
    Effect of Psychological Care Combined with Traditional Chinese Medicine on Postoperative Psychological Stress Response in Patients with Advanced Cervical Cancer.
    Evid Based Complement Alternat Med. 2021;2021:5612925.
    PubMed    
    Abstract available

  71. WILSON JM, Davies E, Tan X, Brewster W, et al
    Demographic and clinical factors associated with variations in opioid administration using conscious sedation during HDR brachytherapy for cervical cancer.
    Brachytherapy. 2021 Oct 4. pii: S1538-4721(21)00458.
    PubMed    
    Abstract available

  72. PAN L, Zhang X, Wang D, Huang M, et al
    DCLK1 might be a therapeutic target of osthole against cervical cancer.
    Pharmazie. 2021;76:503-506.
    PubMed    
    Abstract available

  73. NARVA SI, Seppanen MP, Raiko JRH, Forsback SJ, et al
    Imaging of Tumor Hypoxia With 18F-EF5 PET/MRI in Cervical Cancer.
    Clin Nucl Med. 2021 Oct 4. pii: 00003072-900000000-95826.
    PubMed    
    Abstract available

  74. DAVIS K, Kwon R, Graham A, White M, et al
    Comparison of Cervical Cancer Screen Results on Female-to-Male Transgender Patients With Female Patients.
    Am J Clin Pathol. 2021 Oct 7. pii: 6383033. doi: 10.1093.
    PubMed    
    Abstract available

  75. ROMERO D
    Pembrolizumab tunes up chemotherapy in cervical cancer.
    Nat Rev Clin Oncol. 2021 Oct 6. pii: 10.1038/s41571-021-00570.
    PubMed    


  76. CHINN JO, Runge AS, Dinicu AI, Chang J, et al
    Visual inspection with acetic acid screening for cervical cancer among women receiving anti-retroviral therapy for human immunodeficiency virus infection in northern Tanzania.
    J Obstet Gynaecol Res. 2021 Oct 6. doi: 10.1111/jog.15011.
    PubMed    
    Abstract available

  77. CHOU MH, Meng E, Wu ST, Cha TL, et al
    Increased incidence of neurogenic bladder after radical hysterectomy for cervical cancer: A nationwide population-based cohort study.
    J Chin Med Assoc. 2021;84:942-950.
    PubMed    
    Abstract available

  78. NAGIREDDY PKR, Kumar D, Kommalapati VK, Pedapati RK, et al
    9-Ethynyl noscapine induces G2/M arrest and apoptosis by disrupting tubulin polymerization in cervical cancer.
    Drug Dev Res. 2021 Oct 6. doi: 10.1002/ddr.21888.
    PubMed    
    Abstract available

  79. LIU CH, Kung YH, Lin JC, Chuang CM, et al
    Synergistic therapeutic effect of low-dose bevacizumab with cisplatin-based chemotherapy for advanced or recurrent cervical cancer.
    J Chin Med Assoc. 2021 Oct 4. pii: 02118582-900000000-99469.
    PubMed    
    Abstract available

  80. LI J, Gong X, Li P, Ouyang X, et al
    Preoperative Conization May Have a Positive Impact on Survival in Early-Stage Cervical Cancer: A Propensity-Matched Study.
    Oncol Res Treat. 2021 Oct 5:1-8. doi: 10.1159/000519646.
    PubMed    
    Abstract available

  81. TIE W, Ge F
    MALAT1 Inhibits Proliferation of HPV16-Positive Cervical Cancer by Sponging miR-485-5p to Promote Expression of MAT2A.
    DNA Cell Biol. 2021 Oct 4. doi: 10.1089/dna.2020.6205.
    PubMed    
    Abstract available

  82. RIBEIRO A, Correa F, Migowski A, Leal A, et al
    Rethinking Cervical Cancer Screening in Brazil Post COVID-19: A Global Opportunity to Adopt Higher Impact Strategies.
    Cancer Prev Res (Phila). 2021;14:919-926.
    PubMed    
    Abstract available

  83. BEEKMAN C, Schaake E, Sonke JJ, Remeijer P, et al
    Deformation trajectory prediction using a neural network trained on finite element data - application to library of CTVs creation for cervical cancer.
    Phys Med Biol. 2021 Oct 4. doi: 10.1088/1361-6560.
    PubMed    
    Abstract available

  84. GE F, Tie W, Zhang J, Zhu Y, et al
    Expression of the HOXA gene family and its relationship to prognosis and immune infiltrates in cervical cancer.
    J Clin Lab Anal. 2021 Oct 4:e24015. doi: 10.1002/jcla.24015.
    PubMed    
    Abstract available

  85. KIM KE, Kim CK
    Magnetic resonance imaging-based texture analysis for the prediction of postoperative clinical outcome in uterine cervical cancer.
    Abdom Radiol (NY). 2021 Oct 4. pii: 10.1007/s00261-021-03288.
    PubMed    
    Abstract available


  86. Correction: Five candidate biomarkers associated with the diagnosis and prognosis of cervical cancer.
    Biosci Rep. 2021;41.
    PubMed    


  87. ZHANG G, Miao L, Wu H, Zhang Y, et al
    Pretreatment Squamous Cell Carcinoma Antigen (SCC-Ag) as a Predictive Factor for the Use of Consolidation Chemotherapy in Cervical Cancer Patients After Postoperative Extended-Field Concurrent Chemoradiotherapy.
    Technol Cancer Res Treat. 2021;20:15330338211044626.
    PubMed    
    Abstract available

  88. ZUBERY MH, Rahman FB, Islam MN, Datta A, et al
    A Comparative Study between Magnetic Resonance Imaging and Clinical FIGO Criteria in Different Stages of Carcinoma Cervix.
    Mymensingh Med J. 2021;30:1131-1138.
    PubMed    
    Abstract available

  89. SHAHNAZ S, Hira HM, Begum KN, Akhter R, et al
    "Screen and Treat" Approach among VIA Positive Women during Cervical Cancer Screening Program: Experience at Low Resource Setting.
    Mymensingh Med J. 2021;30:1100-1106.
    PubMed    
    Abstract available

  90. GUL OV, Inan G, Basaran H
    Impact of different treatment plans on EQD2 for intracavitary brachytherapy of cervical cancer.
    J Egypt Natl Canc Inst. 2021;33:28.
    PubMed    
    Abstract available

  91. AREDO MA, Sendo EG, Deressa JT
    Knowledge of cervical cancer screening and associated factors among women attending maternal health services at Aira Hospital, West Wollega, Ethiopia.
    SAGE Open Med. 2021;9:20503121211047063.
    PubMed    
    Abstract available

  92. ABUGU LI, Nwagu EN
    Awareness, knowledge and screening for cervical cancer among women of a faith-based organization in Nigeria.
    Pan Afr Med J. 2021;39:200.
    PubMed    
    Abstract available

  93. GAO L, Lv J, Hou L, Yuan Y, et al
    Clinical Effects of Chinese Herbal Decoction Combined with Basic Chemoradiotherapy and Nursing Intervention in the Treatment of Cervical Cancer and the Effect on Serum CEA, CA125, and TNF-alpha Levels.
    Evid Based Complement Alternat Med. 2021;2021:1446864.
    PubMed    
    Abstract available

  94. GUPTA R, Sharda A, Kumar D, Fulzele R, et al
    Cervical Cancer Screening: Is the Age Group 30-65 Years Optimum for Screening in Low-Resource Settings?
    J Obstet Gynaecol India. 2021;71:530-536.
    PubMed    
    Abstract available

  95. LUCES LAGO AM, Mosquera Pan L, Lopez Folgueiras B, Tizon Bouza E, et al
    [New approach in the Screening Program for the early detection of cervical cancer in Galicia.]
    Rev Esp Salud Publica. 2021;95.
    PubMed    
    Abstract available

  96. DILLNER J, Elfstrom KM, Baussano I
    Prospects for accelerated elimination of cervical cancer.
    Prev Med. 2021 Sep 29:106827. doi: 10.1016/j.ypmed.2021.106827.
    PubMed    
    Abstract available

  97. SILVER M, Anderson ML, Beaber EF, Haas JS, et al
    De-implementation of cervical cancer screening before age 21.
    Prev Med. 2021 Sep 29:106815. doi: 10.1016/j.ypmed.2021.106815.
    PubMed    
    Abstract available

  98. HU S, Hao Y, Zhang X, Yang Y, et al
    Lacticaseibacillus casei LH23 Suppressed HPV Gene Expression and Inhibited Cervical Cancer Cells.
    Probiotics Antimicrob Proteins. 2021 Oct 2. pii: 10.1007/s12602-021-09848.
    PubMed    
    Abstract available

  99. WISER A, Quinlan JD, Batur P
    Risk-based guidelines: Redefining management of abnormal cervical cancer screening results.
    Cleve Clin J Med. 2021;88:556-560.
    PubMed    
    Abstract available

  100. MAHANTSHETTY U, Lewis S, Engineer R, Swamidas J, et al
    Low-Dose-Rate versus High-Dose-Rate intracavitary brachytherapy in cervical cancer - Final Results of a Phase III randomized trial.
    Brachytherapy. 2021 Sep 28. pii: S1538-4721(21)00479.
    PubMed    
    Abstract available

  101. SASSI I, Ghalleb M, Chemlali M, Mbarek M, et al
    Uterine cervix metastasis from primary colon adenocarcinoma: a case report and review of the literature.
    J Med Case Rep. 2021;15:486.
    PubMed    
    Abstract available

  102. ELSHAMI M, Al-Slaibi I, Abukmail H, Alser M, et al
    Knowledge of Palestinian women about cervical cancer warning signs: a national cross- sectional study.
    BMC Public Health. 2021;21:1779.
    PubMed    
    Abstract available

  103. BORDEAUX SJ, Baca AW, Begay RL, Gachupin FC, et al
    Designing Inclusive HPV Cancer Vaccines and Increasing Uptake among Native Americans-A Cultural Perspective Review.
    Curr Oncol. 2021;28:3705-3716.
    PubMed    
    Abstract available

  104. NDIAYE M, Sawadogo B, Sonko I, Ba IO, et al
    [Factors associated with scale-up human papillomavirus (HPV) vaccine in Senegal: a case-control survey of parents].
    Pan Afr Med J. 2021;39:137.
    PubMed    
    Abstract available

  105. CARCEA F, Vavoulidis E, Petousis S, Papandreou P, et al
    Diagnostic performance of HPV E6/E7 mRNA testing towards HPV-DNA testing and p16/Ki67 immunostaining as a biomarker of high-risk HPV recurrence in Greek women surgically treated for their cervical lesions.
    J Obstet Gynaecol Res. 2021;47:3607-3617.
    PubMed    
    Abstract available

  106. BITARAFAN F, Hekmat MR, Khodaeian M, Razmara E, et al
    Prevalence and Genotype Distribution of Human Papillomavirus Infection among 12 076 Iranian Women.
    Int J Infect Dis. 2021;111:295-302.
    PubMed    
    Abstract available

  107. LIU X, Guo R, Xu Y
    B7-H6 as a Diagnostic Biomarker for Cervical Squamous Cell Carcinoma.
    Genet Test Mol Biomarkers. 2021;25:463-470.
    PubMed    
    Abstract available

  108. KAWANO K, Tsuda N, Nasu H, Tasaki S, et al
    Human papillomavirus genotyping predicts residual/recurrent disease after local treatment for cervical intraepithelial neoplasia better than viral DNA testing.
    J Obstet Gynaecol Res. 2021;47:3628-3633.
    PubMed    
    Abstract available

  109. WANG X, Zhou N, Liu T, Jia X, et al
    Oncolytic Vaccinia Virus Expressing White-Spotted Charr Lectin Regulates Antiviral Response in Tumor Cells and Inhibits Tumor Growth In Vitro and In Vivo.
    Mar Drugs. 2021;19.
    PubMed    
    Abstract available

  110. ENOKIDA T, Moreira A, Bhardwaj N
    Vaccines for immunoprevention of cancer.
    J Clin Invest. 2021;131.
    PubMed    
    Abstract available

  111. TANAKA M, Kondo J, Kaneko K, Endo H, et al
    Heterogenous chemosensitivity of a panel of organoid lines derived from small cell neuroendocrine carcinoma of the uterine cervix.
    Hum Cell. 2021;34:889-900.
    PubMed    
    Abstract available

  112. PALEFSKY JM, Poongulali S, Lensing S, Lee J, et al
    AIDS Malignancy Consortium 054: Safety and Immunogenicity of the Quadrivalent vaccine in Indian Women Living with HIV.
    J Acquir Immune Defic Syndr. 2021 Feb 11. pii: 00126334-900000000-95943.
    PubMed    
    Abstract available

  113. SATARI M, Javani Jouni F, Abolmaleki P, Soleimani H, et al
    Influence of Static Magnetic Field on HeLa and Huo2 Cells in the Presence of Aloe vera Extract.
    Asian Pac J Cancer Prev. 2021;22.
    PubMed    
    Abstract available

  114. HIDAYAT YM, Wagey F, Suardi D, Susanto H, et al
    Analysis of Curcumin as a Radiosensitizer in Cancer Therapy with Serum Survivin Examination: Randomised Control Trial.
    Asian Pac J Cancer Prev. 2021;22:139-143.
    PubMed    
    Abstract available

  115. DASGUPTA P, Aitken JF, Condon J, Garvey G, et al
    Temporal and area-level variation in prevalence of high-grade histologically confirmed cervical abnormalities among Indigenous and non-Indigenous women, Queensland, Australia, 2008-2017.
    J Med Screen. 2021;28:341-348.
    PubMed    
    Abstract available

  116. HOSSEINI N, Shoja Z, Younesi S, Shafiei-Jandaghi NZ, et al
    Lineage analysis of human papillomavirus types 31 and 45 in cervical samples of Iranian women.
    J Med Virol. 2021;93:3857-3864.
    PubMed    
    Abstract available

  117. SPASIC S, Ordobazari A, Nadji M, Huang M, et al
    Papillary Squamous Cell Carcinoma of the Uterine Cervix: Biopsy Samples Frequently Underrepresent the Presence of Stromal Invasion.
    Int J Gynecol Pathol. 2021;40:408-412.
    PubMed    
    Abstract available

  118. LI S, Ye M, Chen Y, Gong Q, et al
    Genetic variation of E6 and E7 genes of human papillomavirus 52 from Central China.
    J Med Virol. 2021;93:3849-3856.
    PubMed    
    Abstract available

  119. FAKHR E, Modic Z, Cid-Arregui A
    Recent developments in immunotherapy of cancers caused by human papillomaviruses.
    Immunology. 2021;163:33-45.
    PubMed    
    Abstract available

  120. FENG D, Yan K, Liang H, Liang J, et al
    CBP-mediated Wnt3a/beta-catenin signaling promotes cervical oncogenesis initiated by Piwil2.
    Neoplasia. 2021;23:1-11.
    PubMed    
    Abstract available

  121. HILL E, Nemec M, Marlow L, Sherman SM, et al
    Maximising the acceptability of extended time intervals between screens in the NHS Cervical Screening Programme: An online experimental study.
    J Med Screen. 2021;28:333-340.
    PubMed    
    Abstract available

  122. BENEVOLO M, Mancuso P, Allia E, Gustinucci D, et al
    Determinants of p16/Ki-67 adequacy and positivity in HPV-positive women from a screening population.
    Cancer Cytopathol. 2021;129:383-393.
    PubMed    
    Abstract available

  123. GRIESINGER LM, Szczepanski JM, McMullen ER, Skala SL, et al
    Uncommon Cervical Lesions: A Review and Discussion of the Differential Diagnosis.
    Arch Pathol Lab Med. 2021;145:891-902.
    PubMed    
    Abstract available

  124. HAWARI R, Fernandes L, Park KJ, McCluggage WG, et al
    Skene's Gland Derivatives in the Female Genital Tract and Cervical Adenoid Basal Carcinoma are Consistently Positive With Prostatic Marker NKX3.1.
    Int J Gynecol Pathol. 2021;40:400-407.
    PubMed    
    Abstract available

  125. LI P, Fang Z, Li W, Hao M, et al
    Impact of neoadjuvant chemotherapy on the postoperative pathology of locally advanced cervical squamous cell carcinomas: 1:1 propensity score matching analysis.
    Eur J Surg Oncol. 2021;47:1069-1074.
    PubMed    
    Abstract available

  126. XU J, Park KJ, Weisman P
    A Novel Ciliated, Mucin-producing Variant of HPV-related Cervical Adenosquamous Carcinoma In Situ: A Case Report.
    Int J Gynecol Pathol. 2021;40:413-418.
    PubMed    
    Abstract available

  127. BRZOSKA P, Aksakal T, Yilmaz-Aslan Y
    Disparities in the use of regular pap smears among migrant and non-migrant women in Austria: A population-based survey of 7633 women.
    J Med Screen. 2021;28:372-376.
    PubMed    
    Abstract available

  128. CASTANON A, Sheikh S, Pearmain P, Sasieni P, et al
    Impact of changes to cervical screening guidelines on age and interval at which women are tested: Population-based study.
    J Med Screen. 2021;28:325-332.
    PubMed    
    Abstract available

  129. WANG Z, Li F, He S, Zhao L, et al
    Period circadian regulator 2 suppresses drug resistance to cisplatin by PI3K/AKT pathway and improves chronochemotherapeutic efficacy in cervical cancer.
    Gene. 2021 Oct 11:146003. doi: 10.1016/j.gene.2021.146003.
    PubMed    
    Abstract available

  130. PAN S, Jiang W, Xie S, Zhu H, et al
    Clinicopathological Features and Survival of Adolescent and Young Adults with Cervical Cancer.
    Cancer Control. 2021;28:10732748211051558.
    PubMed    
    Abstract available

  131. ZHANG Q, Guo J, Ouyang H, Chen S, et al
    Added-value of dynamic contrast-enhanced MRI on prediction of tumor recurrence in locally advanced cervical cancer treated with chemoradiotherapy.
    Eur Radiol. 2021 Oct 13. pii: 10.1007/s00330-021-08279.
    PubMed    
    Abstract available

  132. CHANG Y, Wang Z, Peng Z, Zhou J, et al
    Clinical application and improvement of a CNN-based autosegmentation model for clinical target volumes in cervical cancer radiotherapy.
    J Appl Clin Med Phys. 2021 Oct 13. doi: 10.1002/acm2.13440.
    PubMed    
    Abstract available

  133. ZHOU Y, Gu HL, Zhang XL, Tian ZF, et al
    Multiparametric magnetic resonance imaging-derived radiomics for the prediction of disease-free survival in early-stage squamous cervical cancer.
    Eur Radiol. 2021 Oct 12. pii: 10.1007/s00330-021-08326.
    PubMed    
    Abstract available

  134. RASPAGLIO G, Buttarelli M, Filippetti F, Battaglia A, et al
    Stat1 confers sensitivity to radiation in cervical cancer cells by controlling Parp1 levels: a new perspective for Parp1 inhibition.
    Cell Death Dis. 2021;12:933.
    PubMed    
    Abstract available

  135. LI X, Wang L, Cui Z, Li Y, et al
    Correction to: Online MR evaluation of inter- and intra-fraction uterus motions and bladder volume changes during cervical cancer external beam radiotherapy.
    Radiat Oncol. 2021;16:200.
    PubMed    


  136. LV H, Jin S, Zou B, Liang Y, et al
    Analyzing the whole-transcriptome profiles of ncRNAs and predicting the competing endogenous RNA networks in cervical cancer cell lines with cisplatin resistance.
    Cancer Cell Int. 2021;21:532.
    PubMed    
    Abstract available

  137. WALSH RJ, Tan DSP
    The Role of Immunotherapy in the Treatment of Advanced Cervical Cancer: Current Status and Future Perspectives.
    J Clin Med. 2021;10.
    PubMed    
    Abstract available

  138. HERRMANN AL, Kuhn BJ, Holzer A, Krijgsveld J, et al
    Delineating the Switch between Senescence and Apoptosis in Cervical Cancer Cells under Ciclopirox Treatment.
    Cancers (Basel). 2021;13.
    PubMed    
    Abstract available

  139. YU Y, Matsuyama R, Tsunematsu M, Kakehashi M, et al
    Quantifying the Effects of Medical Examination and Possible Risk Factors against the Incidence of Cervical Cancer in a Low Human Papillomavirus Vaccination Coverage: An Ecological Study in Japan.
    Cancers (Basel). 2021;13.
    PubMed    
    Abstract available

  140. CHEN J, Zhao S, Tan W, Wang T, et al
    Attenuated Salmonella carrying plasmid co-expressing HPV16 L1 and siRNA-E6 for cervical cancer therapy.
    Sci Rep. 2021;11:20083.
    PubMed    
    Abstract available

  141. HARPER DM, Rozek LS
    Streamlining the WHO cervical cancer elimination goal.
    Lancet Oncol. 2021 Oct 8. pii: S1470-2045(21)00487.
    PubMed    


  142. JUNG W, Kim YH, Kim KS
    Ovarian Function Preservation in Patients With Cervical Cancer Undergoing Hysterectomy and Ovarian Transposition Before Pelvic Radiotherapy.
    Technol Cancer Res Treat. 2021;20:15330338211042140.
    PubMed    
    Abstract available

  143. BIRGE O, Bakir MS, Karadag C, Dogan S, et al
    Evaluation of elderly women with uterin cervical cancer.
    Cancer Rep (Hoboken). 2021 Oct 10:e1570. doi: 10.1002/cnr2.1570.
    PubMed    
    Abstract available

  144. NEGI SS, Sharma K, Sharma D, Singh P, et al
    Genetic analysis of human papilloma virus 16 E6/E7 variants obtained from cervical cancer cases in Chhattisgarh, a central state of India.
    Virusdisease. 2021;32:492-503.
    PubMed    
    Abstract available

  145. HAN Q, Kim SI, Yoon SH, Kim TM, et al
    Impact of Computed Tomography-Based, Artificial Intelligence-Driven Volumetric Sarcopenia on Survival Outcomes in Early Cervical Cancer.
    Front Oncol. 2021;11:741071.
    PubMed    
    Abstract available

  146. BAI Y, Li H, Lv R
    Interleukin-17 activates JAK2/STAT3, PI3K/Akt and nuclear factor-kappaB signaling pathway to promote the tumorigenesis of cervical cancer.
    Exp Ther Med. 2021;22:1291.
    PubMed    
    Abstract available

  147. YU J, Liang LL, Liu J, Liu TT, et al
    Development and Validation of a Novel Gene Signature for Predicting the Prognosis by Identifying m5C Modification Subtypes of Cervical Cancer.
    Front Genet. 2021;12:733715.
    PubMed    
    Abstract available

  148. RACI PZ, Raci F, Hadri T
    Kosovo women's knowledge and awareness of human papillomavirus (HPV) infection, HPV vaccination, and its relation to cervical cancer.
    BMC Womens Health. 2021;21:354.
    PubMed    
    Abstract available

  149. LIU Y, Xu C, Pan J, Sun C, et al
    Significance of the viral load of high-risk HPV in the diagnosis and prediction of cervical lesions: a retrospective study.
    BMC Womens Health. 2021;21:353.
    PubMed    
    Abstract available

  150. CHEN XY, Qin JF, Tang LW, Zhang RR, et al
    [Construction and application of home self-sampling processes for cervical human papillomavirus detection].
    Zhonghua Yu Fang Yi Xue Za Zhi. 2021;55:1145-1148.
    PubMed    
    Abstract available

  151. SAGNIC S, Birge O, Bakir MS, Karadag C, et al
    Clinicopathological Analysis of Neuroendocrine Carcinoma of the Uterine Cervix: A Single-Institution Retrospective Review of 9 Cases.
    Int J Surg Oncol. 2021;2021:8290659.
    PubMed    
    Abstract available

  152. YOCK AD, Ahmed M, Ayala-Peacock D, Chakravarthy AB, et al
    Initial analysis of the dosimetric benefit and clinical resource cost of CBCT-based online adaptive radiotherapy for patients with cancers of the cervix or rectum.
    J Appl Clin Med Phys. 2021;22:210-221.
    PubMed    
    Abstract available

  153. HAWKES D
    Human papillomavirus assay design is a crucial consideration for self-collection based cervical screening.
    Med J Malaysia. 2021;76:718.
    PubMed    
    Abstract available

  154. RAHAMAN MM, Li C, Yao Y, Kulwa F, et al
    DeepCervix: A deep learning-based framework for the classification of cervical cells using hybrid deep feature fusion techniques.
    Comput Biol Med. 2021;136:104649.
    PubMed    
    Abstract available

  155. CLARK EH, Gilman RH, Chiao EY, Gravitt PE, et al
    Gut Helminth Infection-Induced Immunotolerance and Consequences for Human Papillomavirus Persistence.
    Am J Trop Med Hyg. 2021;105:573-583.
    PubMed    
    Abstract available

  156. SERBAN M, Fokdal L, Nielsen SK, Hokland SB, et al
    Characterization of combined intracavitary/interstitial brachytherapy including oblique needles in locally advanced cervix cancer.
    Brachytherapy. 2021;20:796-806.
    PubMed    
    Abstract available

  157. SITARZ K, Kopec J, Zawilinska B, Klimek M, et al
    Sequence variation analysis of the E1 and E2 genes of human papillomavirus type 16 in cervical lesions in women from the south of Poland.
    Acta Biochim Pol. 2021;68:341-346.
    PubMed    
    Abstract available

  158. LIU S, Yuan Z, Qiao X, Liu Q, et al
    Light scattering pattern specific convolutional network static cytometry for label-free classification of cervical cells.
    Cytometry A. 2021;99:610-621.
    PubMed    
    Abstract available

  159. YIN G, Zhang Y, Chen C, Ren H, et al
    Have you ever heard of Human Papillomavirus (HPV) vaccine? The awareness of HPV vaccine for college students in China based on meta-analysis.
    Hum Vaccin Immunother. 2021;17:2736-2747.
    PubMed    
    Abstract available

  160. XU H, Song K, Qin L, Qu Y, et al
    Knowledge of Chinese dentists on HPV, their willingness and barriers to recommend HPV vaccination to patients.
    Hum Vaccin Immunother. 2021;17:2728-2735.
    PubMed    
    Abstract available

  161. SOOD S, Gurram L, Aravindakshan D, Paul J, et al
    Reporting of dose-volume specifications for "Martinez Universal Perineal Interstitial Template-based interstitial high-dose-rate brachytherapy for gynecological cancers" according to International Commission on Radiation Units and Measurements 58 with
    Brachytherapy. 2021;20:550-556.
    PubMed    
    Abstract available

  162. THARAVICHITKUL E, Muangwong P, Chakrabandhu S, Klunklin P, et al
    Comparison of clinical outcomes achieved with image-guided adaptive brachytherapy for cervix cancer using CT or transabdominal ultrasound.
    Brachytherapy. 2021;20:543-549.
    PubMed    
    Abstract available

  163. KUNOGI H, Yamaguchi N, Terao Y, Sasai K, et al
    Dosimetric predictors of nephrotoxicity in patients receiving extended-field radiation therapy for gynecologic cancer.
    Radiat Oncol. 2021;16:25.
    PubMed    
    Abstract available

  164. SHARMA P, Gupta P, Gupta N, Suri V, et al
    Evaluation of the Performance of CinTec(R) PLUS in SurePathTM Liquid-Based Cervico-Vaginal Samples.
    Turk Patoloji Derg. 2021;37:32-38.
    PubMed    
    Abstract available

  165. CLIFFORD RE, Gerrard AD, Fok M, Vimalachandran D, et al
    Metformin as a radiosensitiser for pelvic malignancy: A systematic review of the literature.
    Eur J Surg Oncol. 2021;47:1252-1257.
    PubMed    
    Abstract available

  166. SHI H, Shao Y, Lu W, Lu B, et al
    An analysis of HER2 amplification in cervical adenocarcinoma: correlation with clinical outcomes and the International Endocervical Adenocarcinoma Criteria and Classification.
    J Pathol Clin Res. 2021;7:86-95.
    PubMed    
    Abstract available

  167. IHEAGWARA UK, Vargo JA, Boisen MM, Taylor SE, et al
    Regional Control and Chemoradiotherapy Dose Response for Clinically Involved Lymph Nodes in Patients with Locally Advanced Endometrial Cancers Who are Not Candidates for Upfront Surgical Staging Extrafascial Hysterectomy.
    Clin Oncol (R Coll Radiol). 2021;33:e110-e117.
    PubMed    
    Abstract available

  168. PUNTAMBEKAR SP, Goel A, Chandak S, Chitale M, et al
    Feasibility of robotic radical hysterectomy (RRH) with a new robotic system. Experience at Galaxy Care Laparoscopy Institute.
    J Robot Surg. 2021;15:451-456.
    PubMed    
    Abstract available

  169. AGNIHOTRI SK, Kar P, Singh M, Pant G, et al
    Modulation of protein phosphatase 1 gamma 2 during cell division of cervical cancer HeLa cells.
    Contemp Oncol (Pozn). 2021;25:125-132.
    PubMed    
    Abstract available

  170. XU Y, Chen X, Pan S, Wang ZW, et al
    TM7SF2 regulates cell proliferation and apoptosis by activation of C-Raf/ERK pathway in cervical cancer.
    Cell Death Discov. 2021;7:299.
    PubMed    
    Abstract available

  171. LI B, Sui L
    Metabolic reprogramming in cervical cancer and metabolomics perspectives.
    Nutr Metab (Lond). 2021;18:93.
    PubMed    
    Abstract available

  172. ZENG J, He SL, Li LJ, Wang C, et al
    Hsp90 up-regulates PD-L1 to promote HPV-positive cervical cancer via HER2/PI3K/AKT pathway.
    Mol Med. 2021;27:130.
    PubMed    
    Abstract available

  173. CHEN J, Ge L, Shi X, Liu J, et al
    Lobaplatin induces pyroptosis in cervical cancer cells via caspase-3/GSDME pathway.
    Anticancer Agents Med Chem. 2021 Oct 17. pii: ACAMC-EPUB-118489.
    PubMed    
    Abstract available

  174. GENG Y, Wang M, Yang S, Zhao H, et al
    The prognosis of "sandwich" mode of postoperative chemotherapy and radiation in patients with locally advanced cervical cancer.
    J Obstet Gynaecol Res. 2021 Oct 18. doi: 10.1111/jog.15069.
    PubMed    
    Abstract available

  175. ZHANG X, Zhang A, Zhang X, Hu S, et al
    ERa-36 instead of ERa mediates the stimulatory effects of estrogen on the expression of viral oncogenes HPV E6/E7 and the malignant phenotypes in cervical cancer cells.
    Virus Res. 2021 Oct 15:198602. doi: 10.1016/j.virusres.2021.198602.
    PubMed    
    Abstract available

  176. PETERSON CE, Silva A, Goben AH, Ongtengco NP, et al
    Stigma and cervical cancer prevention: A scoping review of the U.S. literature.
    Prev Med. 2021;153:106849.
    PubMed    
    Abstract available

  177. WANG Y, Liu R, Liao J, Jiang L, et al
    Orthogonal ubiquitin transfer reveals human papillomavirus E6 downregulates nuclear transport to disarm interferon-gamma dependent apoptosis of cervical cancer cells.
    FASEB J. 2021;35:e21986.
    PubMed    
    Abstract available

  178. ALHAMLAN FS, Alfageeh MB, Al Mushait MA, Al-Badawi IA, et al
    Human Papillomavirus-Associated Cancers.
    Adv Exp Med Biol. 2021;1313:1-14.
    PubMed    
    Abstract available

  179. SALEHINIYA H, Momenimovahed Z, Allahqoli L, Momenimovahed S, et al
    Factors related to cervical cancer screening among Asian women.
    Eur Rev Med Pharmacol Sci. 2021;25:6109-6122.
    PubMed    
    Abstract available

  180. WU X, Li L, Li Y, Jiang M, et al
    Prognostic value of serological markers of hepatitis B virus infection in squamous cell cervical cancer.
    J Cancer. 2021;12:6620-6628.
    PubMed    
    Abstract available

  181. WANG T, Zhang W, Huang W, Hua Z, et al
    LncRNA MALAT1 was regulated by HPV16 E7 independently of pRB in cervical cancer cells.
    J Cancer. 2021;12:6344-6355.
    PubMed    
    Abstract available

  182. LAN C, Liu CC, Nie XC, Lei L, et al
    FAM83A Promotes the Proliferative and Invasive Abilities of Cervical Cancer Cells via Epithelial-Mesenchymal Transition and the Wnt Signaling Pathway.
    J Cancer. 2021;12:6320-6329.
    PubMed    
    Abstract available

  183. CHEN J, Zhou C, Yi J, Sun J, et al
    Metformin and arsenic trioxide synergize to trigger Parkin/pink1-dependent mitophagic cell death in human cervical cancer HeLa cells.
    J Cancer. 2021;12:6310-6319.
    PubMed    
    Abstract available

  184. WAN L, Zhu J, Wu Q
    Knockdown of DIAPH3 Inhibits the Proliferation of Cervical Cancer Cells through Inactivating mTOR Signaling Pathway.
    J Oncol. 2021;2021:4228241.
    PubMed    
    Abstract available

  185. MA L, Li Q, Guo Y, Tan X, et al
    Laparoscopic nervesparing radical hysterectomy for the treatment of cervical cancer: a meta-analysis of randomized controlled trials.
    World J Surg Oncol. 2021;19:301.
    PubMed    
    Abstract available

  186. ENYAN NIE, Akaba S, Amoo SA
    Women diagnosed with HIV and unknown HIV status perceived susceptibility to cervical cancer and perceived benefits of cervical cancer screening in Ghana: a cross-sectional study.
    BMC Womens Health. 2021;21:367.
    PubMed    
    Abstract available

  187. XIAO X, Sun H
    Investigation and Follow-up of HPV Infection on Married Mongolian Women in Hulunbuir.
    Clin Lab. 2021;67.
    PubMed    
    Abstract available

  188. ZHANG Y, Zhang KY, Jia HD, Fang X, et al
    Feasibility of Predicting Pelvic Lymph Node Metastasis Based on IVIM-DWI and Texture Parameters of the Primary Lesion and Lymph Nodes in Patients with Cervical Cancer.
    Acad Radiol. 2021 Oct 12. pii: S1076-6332(21)00387.
    PubMed    
    Abstract available

  189. ORTIZ AP, Gierbolini-Bermudez A, Ramos-Cartagena JM, Colon-Lopez V, et al
    Cervical Cancer Screening Among Medicaid Patients During Natural Disasters and the COVID-19 Pandemic in Puerto Rico, 2016 to 2020.
    JAMA Netw Open. 2021;4:e2128806.
    PubMed    


  190. SCHULTE-FROHLINDE R, Georges D, Clifford GM, Baussano I, et al
    Predicting cohort-specific cervical cancer incidence from population-based HPV prevalence surveys: a worldwide study.
    Am J Epidemiol. 2021 Oct 15. pii: 6397976. doi: 10.1093.
    PubMed    
    Abstract available

  191. SALYER C, Lee J, Lorvick J, Comfort M, et al
    Cervical Cancer Prevention Behaviors Among Criminal-Legal Involved Women from Three U.S. Cities.
    J Womens Health (Larchmt). 2021 Oct 14. doi: 10.1089/jwh.2021.0250.
    PubMed    
    Abstract available

  192. DOU L, Zhang X
    Upregulation of CCT3 promotes cervical cancer progression through FN1.
    Mol Med Rep. 2021;24.
    PubMed    
    Abstract available

  193. CHEN J, Hu Y, Teng Y, Yang B, et al
    Increased Nuclear Transporter Importin 7 Contributes to the Tumor Growth and Correlates With CD8 T Cell Infiltration in Cervical Cancer.
    Front Cell Dev Biol. 2021;9:732786.
    PubMed    
    Abstract available

  194. MA X, Yang M
    The correlation between high-risk HPV infection and precancerous lesions and cervical cancer.
    Am J Transl Res. 2021;13:10830-10836.
    PubMed    
    Abstract available

  195. TONG L, He M, Zou Y, Li Z, et al
    Effects of bundled nursing combined with peer support on psychological state and self-efficacy of patients with cervical cancer undergoing chemotherapy.
    Am J Transl Res. 2021;13:10649-10655.
    PubMed    
    Abstract available

  196. ZHU Y, Shen B, Pei X, Liu H, et al
    CT, MRI, and PET imaging features in cervical cancer staging and lymph node metastasis.
    Am J Transl Res. 2021;13:10536-10544.
    PubMed    
    Abstract available

  197. LI L, Xu XT, Wang LL, Qin SB, et al
    Expression and clinicopathological significance of Foxp3 and VISTA in cervical cancer.
    Am J Transl Res. 2021;13:10428-10438.
    PubMed    
    Abstract available

  198. LIU W, Wu Z, Wang L, Wang Q, et al
    Knockdown of TRIM11 suppresses cell progression and apoptosis of cervical cancer cells via PI3K/AKT pathway.
    Am J Transl Res. 2021;13:10328-10340.
    PubMed    
    Abstract available

  199. DAUM AK, Dittmann J, Jansen L, Peters S, et al
    ITIH5 shows tumor suppressive properties in cervical cancer cells grown as multicellular tumor spheroids.
    Am J Transl Res. 2021;13:10298-10314.
    PubMed    
    Abstract available

  200. FOX CR, Burdeaux S, Downing KT
    A 33-Year-Old Woman in the Third Trimester of Pregnancy Diagnosed with Advanced-Staged Squamous Cell Cervical Carcinoma by Magnetic Resonance Imaging and Biopsy.
    Am J Case Rep. 2021;22:e933639.
    PubMed    
    Abstract available

  201. FREIRE-SALINAS J, Benito R, Azueta A, Gil J, et al
    Genotype Distribution Change After Human Papillomavirus Vaccination in Two Autonomous Communities in Spain.
    Front Cell Infect Microbiol. 2021;11:633162.
    PubMed    
    Abstract available

  202. RAMOS DA SILVA J, Ramos Moreno AC, Silva Sales N, de Oliveira Silva M, et al
    A therapeutic DNA vaccine and gemcitabine act synergistically to eradicate HPV-associated tumors in a preclinical model.
    Oncoimmunology. 2021;10:1949896.
    PubMed    
    Abstract available

  203. CORTES J
    Concordant Sum of Cytology and Colposcopy Is Validated by Guidelines to Evaluate the Evolution of Low-Grade Lesions.
    J Low Genit Tract Dis. 2021;25:329.
    PubMed    


  204. PAK LM, Purad CC, Nadipally S, Rao MP, et al
    Cancer Awareness and Stigma in Rural Assam India: Baseline Survey of the Detect Early and Save Her/Him (DESH) Program.
    Ann Surg Oncol. 2021;28:7006-7013.
    PubMed    
    Abstract available

  205. DIKE S, Freysteinson WM
    Factors Associated With African American Mothers' Perceptions of Human Papillomavirus Vaccination of Their Daughters: An Integrated Literature Review.
    Oncol Nurs Forum. 2021;48:371-389.
    PubMed    
    Abstract available

  206. REZENDE MT, Silva R, Bernardo FO, Tobias AHG, et al
    Cric searchable image database as a public platform for conventional pap smear cytology data.
    Sci Data. 2021;8:151.
    PubMed    
    Abstract available

  207. LIN Y, Wang L, Ye M, Yu KN, et al
    Activation of the cGAS-STING signaling pathway in adenomyosis patients.
    Immun Inflamm Dis. 2021;9:932-942.
    PubMed    
    Abstract available

  208. YANG X, Cao JL, Yang FN, Li XF, et al
    Decreased expression of CLCA2 and the correlating with immune infiltrates in patients with cervical squamous cell carcinoma: A bioinformatics analysis.
    Taiwan J Obstet Gynecol. 2021;60:480-486.
    PubMed    
    Abstract available

  209. BENAVIDEZ GA, Zgodic A, Zahnd WE, Eberth JM, et al
    Disparities in Meeting USPSTF Breast, Cervical, and Colorectal Cancer Screening Guidelines Among Women in the United States.
    Prev Chronic Dis. 2021;18:E37.
    PubMed    
    Abstract available

  210. KANIE Y, Okamura A, Maruyama S, Sakamoto K, et al
    Clinical Significance of Serum Squamous Cell Carcinoma Antigen for Patients with Recurrent Esophageal Squamous Cell Carcinoma.
    Ann Surg Oncol. 2021;28:7990-7996.
    PubMed    
    Abstract available

  211. ZUO T, Levi AW, Lin Q, Abi-Raad R, et al
    High-Risk Human Papillomavirus Testing, Genotyping, and Histopathologic Follow-up in Women With Abnormal Glandular Cells on Papanicolaou Tests.
    Am J Clin Pathol. 2021;156:569-576.
    PubMed    
    Abstract available

  212. YOSHIO K, Nagasaka H, Hisazumi K, Okawa H, et al
    Local Control of Squamous Cell Carcinoma of the Cervix Treated with CT-based Three-dimensional Image-Guided Brachytherapy with or without Central Shielding.
    Acta Med Okayama. 2021;75:79-85.
    PubMed    
    Abstract available

  213. DABI Y, Bendifallah S, Kolanska K, Boudy AS, et al
    Anatomical basis of lymph node detection in gynecologic cancers: a review from a surgical perspective.
    Chin Clin Oncol. 2021;10:15.
    PubMed    
    Abstract available

  214. STUEBS FA, Gass P, Dietl AK, Schulmeyer CE, et al
    Human papilloma virus genotype distribution in women with premalignant or malignant lesions of the uterine cervix.
    Arch Gynecol Obstet. 2021;304:751-758.
    PubMed    
    Abstract available

  215. MARCUS JZ, Abedin Y, Pierz AJ, Taveras Y, et al
    A Pilot Study of Human Papillomavirus Detection in Urine Using a Novel Nucleic Acid Amplification Test.
    J Appl Lab Med. 2021;6:474-479.
    PubMed    
    Abstract available

  216. HARAN M, Kelly JR, Kennedy L, Hennigan K, et al
    An audit of the cervical screening programme in the National Drug Treatment Centre (NDTC).
    Ir J Med Sci. 2021;190:1379-1386.
    PubMed    
    Abstract available

  217. HORIE A, Abiko K, Baba T, Sunada M, et al
    A Novel Direct Approach to the Deep Uterine Vein in Laparoscopic Radical Hysterectomy.
    J Minim Invasive Gynecol. 2021;28:1444-1445.
    PubMed    
    Abstract available

  218. KESER G, Yilmaz G, Pekiner FN
    Assessment of Knowledge Level and Awareness About Human Papillomavirus Among Dental Students.
    J Cancer Educ. 2021;36:664-669.
    PubMed    
    Abstract available

  219. WRIGHT TC JR, Stoler MH, Ferenczy A, Ranger-Moore J, et al
    The CERTAIN Study Results: Adjunctive p16 Immunohistochemistry Use in Cervical Biopsies According to LAST Criteria.
    Am J Surg Pathol. 2021;45:1348-1356.
    PubMed    
    Abstract available

  220. EINBOND LS, Zhou J, Wu HA, Mbazor E, et al
    A novel cancer preventative botanical mixture, TriCurin, inhibits viral transcripts and the growth of W12 cervical cells harbouring extrachromosomal or integrated HPV16 DNA.
    Br J Cancer. 2021;124:901-913.
    PubMed    
    Abstract available

  221. BALACHANDRA S, Kusin SB, Lee R, Blackwell JM, et al
    Blood-based biomarkers of human papillomavirus-associated cancers: A systematic review and meta-analysis.
    Cancer. 2021;127:850-864.
    PubMed    
    Abstract available

  222. GREENLAND NY, Wolsky RJ, Darragh TM, Vohra P, et al
    Gastric-type endocervical adenocarcinoma and cervical cytology: Experience at a general hospital and review of the literature.
    Cytopathology. 2021;32:75-83.
    PubMed    
    Abstract available

  223. YUAN L, Oshilaja O, Sierk A, Zhang G, et al
    Metastatic breast cancer diagnosed on cervical cytology.
    Cytopathology. 2021;32:127-131.
    PubMed    


  224. COSTA AF, Ribeiro MGM, Onofre ASC, de Miranda Onofre FB, et al
    Aneuploidy detection for diagnostic and prognostic use in premalignant and malignant lesions of the uterine cervix: A systematic review.
    Diagn Cytopathol. 2020 Dec 17:e24683. doi: 10.1002/dc.24683.
    PubMed    
    Abstract available

  225. AYDOGAN KIRMIZI D, Baser E, Demir Caltekin M, Onat T, et al
    Concordance of HPV, conventional smear, colposcopy, and conization results in cervical dysplasia.
    Diagn Cytopathol. 2021;49:132-139.
    PubMed    
    Abstract available

  226. NEGRI G, Macciocu E, Cepurnaite R, Kasal A, et al
    Non-human papilloma virus associated adenocarcinomas of the cervix uteri. Cytologic features and diagnostic agreement using whole slide digital cytology imaging.
    Diagn Cytopathol. 2021;49:316-321.
    PubMed    
    Abstract available

  227. GIRAY B, Kabaca C, Uzun MG, Akis S, et al
    Is cervical cytology testing as a part of co-test unnecessary for HPV 16/18-infected women? A retrospective cohort study of 1647 women.
    Diagn Cytopathol. 2021;49:267-272.
    PubMed    
    Abstract available

  228. LIN Q, Lin X, Zhuang X, Tang Y, et al
    The prevalence, genotype distribution of human papillomavirus and cervical cytology in Wenzhou, China: a retrospective research of 7391 cases.
    Diagn Cytopathol. 2021;49:211-218.
    PubMed    
    Abstract available

  229. MEHTA SP, Patel TS, Jana T, Samanta ST, et al
    How useful are cervical Pap smears in detecting endometrial carcinomas? A tertiary cancer center experience.
    Diagn Cytopathol. 2021;49:127-131.
    PubMed    
    Abstract available

  230. WANG T, Pradhan D, Zhang H, Matsko J, et al
    Clinical performance of the aptima HPV assay in 4196 women with positive high-risk HPV and ASC-US cytology: A large women hospital experience.
    Diagn Cytopathol. 2021;49:5-10.
    PubMed    
    Abstract available

  231. MANTRI S, Ravikumar G, Crasta J
    Assessment of cytological features of glandular lesions of the cervix on conventional smear preparations-a comprehensive study from a tertiary care hospital.
    Diagn Cytopathol. 2021;49:388-394.
    PubMed    
    Abstract available

  232. CIBULA D, Dostalek L, Jarkovsky J, Mom CH, et al
    The annual recurrence risk model for tailored surveillance strategy in patients with cervical cancer.
    Eur J Cancer. 2021;158:111-122.
    PubMed    
    Abstract available

  233. EKDAHL L, Eoh KJ, Thumuluru KM, Butler-Manuel SA, et al
    A combination of second trimester oral metronidazole and no sexual intercourse during second and third trimester may reduce late miscarriage and premature delivery after fertility sparing radical trachelectomy.
    Eur J Obstet Gynecol Reprod Biol. 2021;265:90-95.
    PubMed    
    Abstract available

  234. YUKSEL D, Karatas Sahin E, Unsal M, Cakir C, et al
    The prognostic factors in 384 patients with FIGO 2014 stage IB cervical cancer: What is the role of tumor size on prognosis?
    Eur J Obstet Gynecol Reprod Biol. 2021;266:126-132.
    PubMed    
    Abstract available

  235. WEI Y, Wang W, Cheng M, Hong Z, et al
    Clinical evaluation of a real-time optoelectronic device in cervical cancer screening.
    Eur J Obstet Gynecol Reprod Biol. 2021 Sep 28. pii: S0301-2115(21)00482.
    PubMed    
    Abstract available

  236. VAN DER PLAS RCJ, Bos AME, Jurgenliemk-Schulz IM, Gerestein CG, et al
    Fertility-sparing surgery and fertility preservation in cervical cancer: The desire for parenthood, reproductive and obstetric outcomes.
    Gynecol Oncol. 2021 Sep 25. pii: S0090-8258(21)01334.
    PubMed    
    Abstract available

  237. LEVINSON K, Beavis AL, Purdy C, Rositch AF, et al
    Corrigendum to "Beyond Sedlis-A novel histology-specific nomogram for predicting cervical cancer recurrence risk: An NRG/GOG ancillary analysis" [Gynecologic Oncology 162 (2021) 532-538].
    Gynecol Oncol. 2021 Oct 12. pii: S0090-8258(21)01386.
    PubMed    


  238. IBRAHIM KHALIL A, Mpunga T, Wei F, Baussano I, et al
    Age-specific burden of cervical cancer associated with HIV: a global analysis with a focus on sub-Saharan Africa.
    Int J Cancer. 2021 Oct 9. doi: 10.1002/ijc.33841.
    PubMed    
    Abstract available

  239. HARPER DM, Rozek LS
    Cervical cancer prevention becomes more efficient.
    Int J Cancer. 2021 Oct 19. doi: 10.1002/ijc.33851.
    PubMed    


  240. PEDERSEN K, Portnoy A, Sy S, Hansen BT, et al
    Switching clinic-based cervical cancer screening programs to HPV self-sampling: A cost-effectiveness analysis of vaccinated and unvaccinated Norwegian women.
    Int J Cancer. 2021 Oct 18. doi: 10.1002/ijc.33850.
    PubMed    
    Abstract available

  241. OISHI T, Kigawa J, Iwanari O, Kasai T, et al
    Is cytology/HPV co-testing for cervical cancer screening useful in Japan?
    Int J Gynaecol Obstet. 2021 Oct 4. doi: 10.1002/ijgo.13961.
    PubMed    
    Abstract available

  242. WILAILAK S, Kengsakul M, Kehoe S
    Worldwide initiatives to eliminate cervical cancer.
    Int J Gynaecol Obstet. 2021;155 Suppl 1:102-106.
    PubMed    
    Abstract available

  243. BISPO PEREIRA EH, Camilo-Junior DJ, D'avilla SCGP, Mattar NJ, et al
    Comparison of Cervical Cancer Screening Results Among Public and Private Services in Brazil.
    Int J Gynaecol Obstet. 2021 Oct 16. doi: 10.1002/ijgo.13985.
    PubMed    
    Abstract available

  244. ADCOCK A, Stevenson K, Cram F, MacDonald EJ, et al
    He Tapu Te Whare Tangata (sacred house of humanity): Under-screened Maori women talk about HPV self-testing cervical screening clinical pathways.
    Int J Gynaecol Obstet. 2021 Aug 11. doi: 10.1002/ijgo.13873.
    PubMed    
    Abstract available

  245. DATTA A, West C, O'Connor JPB, Choudhury A, et al
    Impact of hypoxia on cervical cancer outcomes.
    Int J Gynecol Cancer. 2021 Sep 30. pii: ijgc-2021-002806.
    PubMed    
    Abstract available

  246. ABU-RUSTUM NR
    ConCerv: a prospective trial of conservative surgery for low-risk early stage cervical cancer, by Schmeler et al.
    Int J Gynecol Cancer. 2021 Sep 24. pii: ijgc-2021-003008.
    PubMed    


  247. VIVEROS-CARRENO D, Rodriguez J, Pareja R
    Incidence of metastasis in circumflex iliac nodes in patients with cervical cancer: a systematic review.
    Int J Gynecol Cancer. 2021 Oct 7. pii: ijgc-2021-003005.
    PubMed    
    Abstract available


  248. Correction: Infection versus cancer: management of actinomyces mimicking cervical cancer or ovarian cancer.
    Int J Gynecol Cancer. 2021;31:1400.
    PubMed    


  249. SOZZI G, Chiantera V
    Vena cava resection and bypass for recurrent cervical cancer.
    Int J Gynecol Cancer. 2021;31:1393.
    PubMed    


  250. OSTRBENK VALENCAK A, Bertram A, Groning A, Poljak M, et al
    Comparison of the clinical and analytical performance of Alinity m HR HPV and cobas 4800 HPV assays in a population-based screening setting.
    J Clin Virol. 2021;140:104851.
    PubMed    
    Abstract available

  251. EKLUND C, Muhr LSA, Lagheden C, Forslund O, et al
    The 2019 HPV Labnet international proficiency study: Need of global Human Papillomavirus Proficiency Testing.
    J Clin Virol. 2021;141:104902.
    PubMed    
    Abstract available

  252. LOCKE A, Shah NR, Fetterman B, Poitras N, et al
    Invasive Cervical Cancer After a Positive Pap Test Result and Negative Human Papillomavirus Test Result.
    Obstet Gynecol. 2021;138:580-581.
    PubMed    


  253. NITECKI R, Floyd J, Lamiman K, Clapp MA, et al
    Outcomes of the First Pregnancy After Fertility-Sparing Surgery for Early-Stage Cervical Cancer.
    Obstet Gynecol. 2021;138:565-573.
    PubMed    
    Abstract available

  254. SCHROLL JB, Serizawa RR, Rebolj M
    Human Papillomavirus Testing in the Last Cervical Screening Round at Age 60-64 Years.
    Obstet Gynecol. 2021;138:389-397.
    PubMed    
    Abstract available

  255. ZHAO Q, Zhai YX, Liu HQ, Shi YA, et al
    [Retracted] MicroRNA4915p suppresses cervical cancer cell growth by targeting hTERT.
    Oncol Rep. 2021;46.
    PubMed    
    Abstract available

  256. CHENG J, Liu B, Wang B, Long X, et al
    Effectiveness comparisons of various therapies for FIGO stage IB2/IIA2 cervical cancer: a Bayesian network meta-analysis.
    BMC Cancer. 2021;21:1078.
    PubMed    
    Abstract available

  257. DERESSA BT, Assefa M, Tafesse E, Kantelhardt EJ, et al
    Contemporary treatment patterns and survival of cervical cancer patients in Ethiopia.
    BMC Cancer. 2021;21:1102.
    PubMed    
    Abstract available

  258. CHEN C, Duan H, Zhang W, Zhao H, et al
    Comparison of survival outcomes with or without Para-aortic lymphadenectomy in surgical patients with stage IB1-IIA2 cervical cancer in China from 2004 to 2016.
    BMC Cancer. 2021;21:1091.
    PubMed    
    Abstract available

  259. ZHAO M, Pu X, Yan YJ, Zhang S, et al
    The quality of life in women with cervical cancer and precancerous lesions of Han and ethnic minorities in Southwest China.
    BMC Cancer. 2021;21:1110.
    PubMed    
    Abstract available

  260. CHEN L, Niu Y, Wan X, Yu L, et al
    Clinicopathological features and outcomes in gastric-type of HPV-independent endocervical adenocarcinomas.
    BMC Cancer. 2021;21:1095.
    PubMed    
    Abstract available

  261. SIMSONE Z, Freivalds T, Bema D, Mikelsone I, et al
    Cancer microcell initiation and determination.
    BMC Cancer. 2021;21:1087.
    PubMed    
    Abstract available

  262. COQUAN E, Brachet PE, Licaj I, Leconte A, et al
    CABOCOL-01 trial: a single-arm phase II study assessing safety and efficacy of Cabozantinib for advanced or metastatic cervical carcinoma after platinum treatment failure.
    BMC Cancer. 2021;21:1054.
    PubMed    
    Abstract available

  263. KAWAMURA M, Koide Y, Murai T, Ishihara S, et al
    The importance of choosing the right strategy to treat small cell carcinoma of the cervix: a comparative analysis of treatments.
    BMC Cancer. 2021;21:1046.
    PubMed    
    Abstract available

  264. ZHONG G, Wang Y, Xie Q, Lin R, et al
    HPV-specific risk assessment of cervical cytological abnormalities.
    BMC Cancer. 2021;21:949.
    PubMed    
    Abstract available

  265. LI X, Xu C, Yu Y, Guo Y, et al
    Prediction of lymphovascular space invasion using a combination of tenascin-C, cox-2, and PET/CT radiomics in patients with early-stage cervical squamous cell carcinoma.
    BMC Cancer. 2021;21:866.
    PubMed    
    Abstract available

  266. AKHAVAN S, Alibakhshi A, Parsapoor M, Alipour A, et al
    Comparison of therapeutic effects of chemo-radiotherapy with neoadjuvant chemotherapy before radical surgery in patients with bulky cervical carcinoma (stage IB3 & IIA2).
    BMC Cancer. 2021;21:667.
    PubMed    
    Abstract available

  267. GRAY P, Kann H, Pimenoff VN, Eriksson T, et al
    Human papillomavirus seroprevalence in pregnant women following gender-neutral and girls-only vaccination programs in Finland: A cross-sectional cohort analysis following a cluster randomized trial.
    PLoS Med. 2021;18:e1003588.
    PubMed    
    Abstract available

  268. LOOPIK DL, van Drongelen J, Bekkers RLM, Voorham QJM, et al
    Cervical intraepithelial neoplasia and the risk of spontaneous preterm birth: A Dutch population-based cohort study with 45,259 pregnancy outcomes.
    PLoS Med. 2021;18:e1003665.
    PubMed    
    Abstract available

  269. ITKIN B, Garcia A, Straminsky S, Adelchanow ED, et al
    Prevalence of HER2 overexpression and amplification in cervical cancer: A systematic review and meta-analysis.
    PLoS One. 2021;16:e0257976.
    PubMed    
    Abstract available

  270. KUGUYO O, Dube Mandishora RS, Thomford NE, Makunike-Mutasa R, et al
    High-risk HPV genotypes in Zimbabwean women with cervical cancer: Comparative analyses between HIV-negative and HIV-positive women.
    PLoS One. 2021;16:e0257324.
    PubMed    
    Abstract available

  271. SHIN HY, Song SY, Jun JK, Kim KY, et al
    Barriers and strategies for cervical cancer screening: What do female university students know and want?
    PLoS One. 2021;16:e0257529.
    PubMed    
    Abstract available

  272. TEMESGEN MM, Alemu T, Shiferaw B, Legesse S, et al
    Prevalence of oncogenic human papillomavirus (HPV 16/18) infection, cervical lesions and its associated factors among women aged 21-49 years in Amhara region, Northern Ethiopia.
    PLoS One. 2021;16:e0248949.
    PubMed    
    Abstract available

  273. TORRES KL, Rondon HHMF, Martins TR, Martins S, et al
    Moving towards a strategy to accelerate cervical cancer elimination in a high-burden city-Lessons learned from the Amazon city of Manaus, Brazil.
    PLoS One. 2021;16:e0258539.
    PubMed    
    Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Cervical Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design:


;